Malignant tumor metastasis inhibitors

Details Malignant tumor metastasis inhibitors Malignant tumor metastasis inhibitors

2005-03-22

2005-03-22

Cook, Rebecca (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

active

06869940

ABSTRACT:
A method for inhibiting bone metastasis of a malignant tumor in a patient who has a cancer excluding breast cancer comprises administering to said patient an effective amount of a compound of the formula (III):wherein R2represents a C1-C10 alkyl group substituted by one or more hydroxyl groups is provided.

REFERENCES:
patent: 6566351 (2003-05-01), Ogata et al.
patent: 0 387 077 (1990-09-01), None
patent: WO 9100855 (1991-01-01), None
patent: WO 9414766 (1994-07-01), None
patent: WO 9527697 (1995-10-01), None
patent: WO 9528162 (1995-10-01), None
Skowronsky et al., Endocrinology (1995), 136(1), 20-6 Abstract only.*
Abe, et al. “A novel vitamin d3 analog, 22-oxa-1,25-dihydroxyvitamin D3, Inhibits The Growth Of Human Breast Cancer In Vitro And In Vivo”, Endocrinology, (1991), 129(2): pp. 832-837, Abstract.
Franceschi, et al, “Regulation of Cellular Adhesion and Fibronectin Synthesis by 1a,25-dihydroxyvitamin D3”, Journal of Biological Chemistry (19870, 262(9): pp. 4165-4171.
Oikawa et al, “Antitumor Effect of 22-oxa-1a,25-dihydroxyvitamin D3, A Potent Angiogenesis Inhibitor, On Rat Mammery Tumor Induced by 7,12-dimethylnez[a]anthracene” Anti-Cancer (1991), 2: pp. 475-480.
Young, et al, “Treating Tumor-Bearing Mice With Vitamin D3Diminishes Tumor-Induced Myelopoiesis And Associated Immunosuppression, And Reduces Tumor Metastasis And Recurrence” Cancer Immunol Innunother (1995) 41,: pp. 37-45.
Hamada et al, “Novel vitamin D3Analogs And Their Potential For Inhibiting Cancer Cell Growth” Drugs of the Future (1993) 18(11):1057-1061.

Affiliated with

Also associated with

Rating

Malignant tumor metastasis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Malignant tumor metastasis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malignant tumor metastasis inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3397342